Affiliation:
1. Department of Biomedical Sciences, Cooper Medical School of Rowan University , Camden, NJ, USA
Abstract
AbstractThe rising prevalence of inflammatory bowel disease (IBD) necessitates that patients be given increased access to cost-effective interventions to manage the disease. Exercise is a non-pharmacologic intervention that advantageously affects clinical aspects of IBD, including disease activity, immune competency, inflammation, quality of life, fatigue, and psychological factors. It is well established that exercise performed at low-to-moderate intensity across different modalities manifests many of these diseased-related benefits while also ensuring patient safety. Much less is known about higher-intensity exercise. The aim of this review is to summarize findings on the relationship between strenuous exercise and IBD-related outcomes. In healthy adults, prolonged strenuous exercise may unfavorably alter a variety of gastrointestinal (GI) parameters including permeability, blood flow, motility, and neuro-endocrine changes. These intensity- and gut-specific changes are hypothesized to worsen IBD-related clinical presentations such as diarrhea, GI bleeding, and colonic inflammation. Despite this, there also exists the evidence that higher-intensity exercise may positively influence microbiome as well as alter the inflammatory and immunomodulatory changes seen with IBD. Our findings recognize that safety for IBD patients doing prolonged strenuous exercise is no more compromised than those doing lower-intensity work. Safety with prolonged, strenuous exercise may be achieved with adjustments including adequate hydration, nutrition, drug avoidance, and careful attention to patient history and symptomatology. Future work is needed to better understand this intensity-dependent relationship so that guidelines can be created for IBD patients wishing to participate in high-intensity exercise or sport.
Publisher
Oxford University Press (OUP)
Reference136 articles.
1. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities;Hanauer;Inflamm Bowel Dis,2006
2. Epidemiology and risk factors for IBD;Ananthakrishnan;Nat Rev Gastroenterol Hepatol,2015
3. Inflammatory bowel disease: historical perspective, epidemiology, and risk factors;Malik;Surg Clin North Am,2015
4. Clinical aspects and pathophysiology of inflammatory bowel disease;Hendrickson;Clin Microbiol Rev,2002
5. Serological markers in inflammatory bowel disease: a review of their clinical utility;Barahona-Garrido;Rev Gastroenterol Mex,2009
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献